Connect with us

Market

Biotechnology Stocks Not Affected By Politics; VBI Vaccines Inc (NASDAQ:VBIV), SCIVAC THERAPEUTICS INC (OTCMKTS:SVACF), Opko Health Inc.(NYSE:OPK)

Published

on

Over the past few months, the biotech sector saw a large sell-off ignited by pricing worries. Democratic Presidential candidate Hillary Clinton’s “price gouging” tweet she posted had ignited the downturn. On the other hand, this was not the first time that a concern over prices has emerged in the biotech sector. Expensive prices of biotech drugs have been topic of discussion, intermittently, for a good amount of time now. Currently, market sentiment looks to be improving sparked by positive earnings, product approvals, improved guidance and boosting pipeline updates. The sector saw a strong rally with stocks reporting strong gains last week. Despite some company’s continued fall, the majority of biotech companies traded have been in the green. Even the NASDAQ Biotech Index has increased by roughly 16% since mid September.

One company in particular has been making a lot of noise in the biotech sector, SCIVAC THERAPEUTICS INC (OTCMKTS:SVACF). The company focuses on developing, producing and marketing biologic products for human healthcare. SciVac’s flagship product, Sci-B-Vac, is a recombinant third-generation hepatitis B vaccine. Currently in the world, there are over 400 million people infected with hepatitis in all forms. In 2014, 1.3 million hepatitis deaths were reported.

SVACF Could Be On The Verge Of A MASSIVE Biotech Breakthrough; CLICK NOW

Also the world’s deadliest form of hepatitis, by infections and deaths per year, hepatitis B leads the race, with more than 240 million infections and 780,000 deaths recorded per year. SciVac’s treatment has already been approved in 10 countries globally, and it has proven to be 98% effective. The amazing statistic is that is proven to be 100% effective on newborns. The pronoun “Warren Buffet of Biotech Stocks”, Phillip Frost has endorsed SciVac and stated, “SCIVAC THERAPEUTICS INC (OTCMKTS:SVACF) intends to pursue marketing approvals for Sci-B-Vac in the United States and other territories worldwide, initially focusing on at-risk populations such as End-Stage Renal Disease and HIV patients.”

How Much Share Does Dr. Philip Frost’s Opko Health Inc. (NYSE:OPK)Own Through This Transaction?

On Oct. 26th the company announced that is entered into an agreement to acquire NASDAQ Company VBI Vaccines Inc (NASDAQ:VBIV) to form a commercial-stage company with a licensed hepatitis B vaccine and plans of a preventative and therapeutic vaccine candidates. Both VBI Vaccines Inc (NASDAQ:VBIV) and SCIVAC will hold a joint conference call for shareholders to discuss the proposed merger on Thursday 3:00pm E.S.T, November 5th, 2015. Over the last 10 days SVACF has rallied 29.23% from lows of $0.13 to highs of $0.168.

About SciVac Therapeutics Inc.
SciVac Therapeutics Inc., headquartered in Rehovot Israel, is in the business of developing, producing and marketing biological products for human healthcare. SciVac’s flagship product, Sci-B-Vac™, is a recombinant third-generation hepatitis B vaccine. SciVac also offers contract development and manufacturing services to the life sciences and biotechnology markets.

Market

ConforMIS Inc (NASDAQ: CFMS): Premium Members Made A Quick 65% Profit In Just 1 week

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy ConforMIS Inc (NASDAQ: CFMS) yesterday (march 13th) at $1.36. Now look at the price of the stock – its up 65% at $2.25 from our buy price. This is how easy money they made. If you had invested $5,000 in CFMS, it could had been moved up to $8,250. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Rockwell Medical Inc (NASDAQ: RMTI): Premium Members Made A Quick 20% Profit In 24 Hours

Published

on

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/
JOIN US NOW: For Details Contact us at info@tradersinsights.com

Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Rockwell Medical Inc (NASDAQ: RMTI) yesterday (march 18th) at $5.42. Now look at the price of the stock – its up 20% at $6.55 from our buy price. This is how easy money they made. If you had invested $5,000 in RMTI, it could had been moved up to $6,000. It’s not yet late, join us at info@tradersinsights.com

Continue Reading

Market

Sorrento Therapeutics Inc (NASDAQ: SRNE): Members Made A Hefty 15% Profit In 24 Hours

Published

on

By

Well, as we know there are two types of person in the stock market one is trader and another is investor. Investors tend to put money for longer time, while traders make short term bets. We know, its not at all easy to make money in the short term especially in the equity markets. However, premium members at Traders Insights are making awesome money on our calls on our swing trading calls. WE ARE OFFERING A SPECIAL 7-Day Trial Period at Just $5 (so that everybody can make money with us and join us if satisfied). Register Here http://tradersinsights.com/pricing/

 JOIN US NOW: For Details Contact us at info@tradersinsights.com

 Or You can send me a friend request on facebook here https://www.facebook.com/sebastian.gomestradersinsights

Now let me show you how we made quick 43% in just 1-week which was posted to our premium members:-

We told our members in facebook private group to buy Sorrento Therapeutics Inc (NASDAQ: SRNE) yesterday (march 18th) at $2.67. Now look at the price of the stock – its up 15% at $3.23 from our buy price. This is how easy money they made. If you had invested $5,000 in SRNE, it could had been moved up to $5,750.  It’s not yet late, join us at info@tradersinsights.com

Continue Reading
Advertisement

Trending